The Court of Justice of the European Union has clarified the conditions for cross-border online sales of medicines not subject to medical prescription in a judgment handed down on Thursday 1 October (Case C-649/18).
The Dutch company A operates a pharmacy in the Netherlands as well as a website targeting French customers for the cross-border marketing of medicines authorised in France and not subject to prescription.
Invoking French regulations governing the sale and advertising of...